All results
1 results for atezolizumab treating patients recurrent bcg unresponsive non muscle invasive bladder
-
Clinical Trials
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…